Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020095912 - BENZIMIDAZOLE DERIVATIVE

Publication Number WO/2020/095912
Publication Date 14.05.2020
International Application No. PCT/JP2019/043342
International Filing Date 05.11.2019
IPC
A61K 31/4184 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
41641,3-Diazoles
4184condensed with carbocyclic rings, e.g. benzimidazoles
A61K 31/4196 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
41961,2,4-Triazoles
A61K 31/422 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
42Oxazoles
422not condensed and containing further heterocyclic rings
A61K 31/427 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
425Thiazoles
427not condensed and containing further heterocyclic rings
A61K 31/4439 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
44Non-condensed pyridines; Hydrogenated derivatives thereof
4427containing further heterocyclic ring systems
4439containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
A61K 31/4745 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
47Quinolines; Isoquinolines
4738ortho- or peri-condensed with heterocyclic ring systems
4745condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenanthrolines
Applicants
  • 第一三共株式会社 DAIICHI SANKYO COMPANY, LIMITED [JP]/[JP]
Inventors
  • 鈴木 亮輔 SUZUKI Ryosuke
  • 片山 勝史 KATAYAMA Katsushi
  • 上野 新也 UENO Shinya
  • 杉本 雄一 SUGIMOTO Yuuichi
  • 渡邉 秀昭 WATANABE Hideaki
Agents
  • 石橋 公樹 ISHIBASHI Koki
  • 竹元 利泰 TAKEMOTO Toshiyasu
Priority Data
2018-20859806.11.2018JP
Publication Language Japanese (JA)
Filing Language Japanese (JA)
Designated States
Title
(EN) BENZIMIDAZOLE DERIVATIVE
(FR) DÉRIVÉ DE BENZIMIDAZOLE
(JA) ベンズイミダゾール誘導体
Abstract
(EN)
Provided is a novel compound that has a 5-HT5A receptor modulating action. The present invention is a compound that is represented by general formula (I) or a pharmaceutically acceptable salt thereof. [In the formula, R1 to R7, A, and L are as defined in the description.]
(FR)
La présente invention concerne un nouveau composé qui a une action de modulation du récepteur 5-HT5A. L'invention concerne un composé qui est représenté par la formule générale (I), ou un sel pharmaceutiquement acceptable de celui-ci. [Dans la formule, R1, à R7, A et L sont tels que définis dans la description.]
(JA)
5-HT5A受容体調節作用を有する新規な化合物を提供すること。 一般式(I)で表される化合物もしくはその薬学的に許容される塩。 [式中、R1~R7、A、及びLの定義に関しては明細書中の記載に従う]
Latest bibliographic data on file with the International Bureau